Objectives: The prevalence of resistance genes in two important anaerobic genera, Bacteroides and Prevotella, was assessed by applying PCR specifically directed to genes of interest. Methods: A total of 101 Bacteroides spp. and 99 Prevotella spp. human clinical isolates were identified using MALDI-TOF MS. The presence of the resistance genes cfxA, cepA, cfiA, tetQ, ermF and nim, was assessed. Prevalence of resistance genes was compared with the phenotypic resistance against amoxicillin, clindamycin, meropenem and metronidazole. Results: Even though the majority of the Bacteroides isolates (95.0%) showed resistance towards amoxicillin, only 52/101 of the isolates harboured one of the resistance genes, accounting for this resistance. Within the genus Prevotella the presence of cfxA (50/99) almost perfectly matched the amoxicillin resistance (48/99). No difference in prevalence of the ermF gene (16/101 and 9/99) and clindamycin resistance (16/101 and 10/99) was observed within Bacteroides and Prevotella, respectively. Two isolates of Prevotella were resistant to metronidazole. One harboured the nim gene. One metronidazolesusceptible isolate of Bacteroides harboured a nim gene. Within the Bacteroides and Prevotella genera, 6/101 strains and 5/99 isolates harboured three different resistance genes, respectively, among them tetQ. TetQ is often located on a conjugative transposon, increasing the chance of horizontal gene transfer between isolates.
Introduction
Members of the phylum Bacteroidetes are a major part of the human commensal oral and gut microbiota. Two anaerobic genera from this phylum, Bacteroides and Prevotella, are regularly isolated from human clinical specimens and are known to play an important role in mixed anaerobic infections. Members of the Bacteroides group are the most prevalent anaerobic bacteria in infections [1] .
As among aerobic bacteria, the antibiotic resistance in anaerobic bacteria is increasing. Decades ago the resistance to clindamycin among the Bacteroides group isolates was 6% [2] compared with 21% in 2015 [3] . Resistance genes among anaerobic bacteria can be exchanged by horizontal gene transfer. Conjugative transposons (CTn) and/or plasmids harbour one or several resistance genes that can be transferred under conditions of, for example, low concentrations of antibiotic [4] . The most studied CTn in anaerobic bacteria is CTnDOT, encountered in several Bacteroides species. This CTn harbours a tetracycline resistance gene, tetQ, regularly accompanied by the ermF gene. The latter causes resistance to clindamycin. The conjugative transfer of CTnDOT is a complex series of events, triggered by exposing the bacterial cell to low concentrations of tetracycline. About 80% of Bacteroides strains are now resistant to tetracycline, as a consequence of its intensive use in the past [5] .
The most important feature for a bacterium to protect itself against b-lactam antibiotics is the production of b-lactamases.
Garcia et al. [6] , described that in Bacteroides the presence of a cfxA gene is the most frequent indicator for b-lactamase production.
Furthermore, b-lactamases can be produced by the cepA gene, which has only been found in Bacteroides fragilis strains [6, 7] . The expression of either the cfxA or cepA gene results in high resistance to penicillins and cephalosporins. A worrisome development is the production of metallo-b-lactamases by Bacteroides strains. This enzyme, encoded by the cfiA gene, cannot be inhibited by b-lactamase inhibitors. Similar to the cepA gene, the cfiA gene is strictly restricted to strains of B. fragilis [8] .
A limited number of studies have been performed on the prevalence of antibiotic-resistance genes in Bacteroides strains isolated from human clinical specimens [7, 9, 10] . Most studies focus on the prevalence of the cfiA gene in B. fragilis [8, 11] . To our knowledge, studies focusing on the prevalence of antibioticresistance genes in the genus Prevotella are scarce.
In this study, we determined the prevalence of resistance genes in Bacteroides and Prevotella isolates obtained from human clinical specimens, at the University Medical Centre, Groningen, the Netherlands. Besides the most prevalent resistance genes against antibiotics used nowadays, we also determined the prevalence of the tetQ gene. In this study the prevalence of cfxA, tetQ, ermF and nim genes in Prevotella and, additionally, of the cepA and cfiA genes in Bacteroides clinical isolates, was assessed.
Material and methods

Bacterial strains
A total of 101 Bacteroides and 99 Prevotella isolates, isolated from a variety of human clinical specimens, were included in this study. All Bacteroides isolates and most Prevotella isolates (n ¼ 77) were collected, consecutively, in 2016; some Prevotella isolates were collected in 2015 (n ¼ 11) and 2017 (n ¼ 11) to obtain a similar number of isolates as for the Bacteroides group. Isolates were revived from the e80 C freezer, subcultured on Brucella blood agar (Mediaproducts, Groningen, the Netherlands), supplemented with haemin (5 mg/L) and vitamin K (1 mg/L), and incubated at 37 C for 48 hours in an anaerobic jar (Mart Microbiology, Drachten, the Netherlands) or anaerobic cabinet (Don Whitley, Bingley, UK). In both cases the anaerobic environment was created from the same gas mixture (80% N 2 , 10% CO 2 , 10% H 2 ). An anaerobic indicator (Oxoid, Badhoevedorp, the Netherlands) was included. Isolates were identified using matrix assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS; Bruker Daltoniks, Bremen, Germany), as described previously [12] . Obtained log scores were interpreted as advised by the manufacturer, e.g. a log score 2 was recorded as an identification with high confidence, log score 1.7 and <2 as an identification with low confidence and a log score <1.7 as no reliable identification. Since MALDI-TOF MS is unable to differentiate between Bacteroides ovatus and Bacteroides xylanisolvens or between Bacteroides vulgatus and Bacteroides dorei [13] , these species were listed as B. ovatus/xylanisolvens and B. vulgatus/dorei, respectively. No patient consent or approval from the ethics committee was required as isolates were obtained during routine microbiological diagnostics and upon admission patients can indicate if they do not want leftover material/isolates being used for research and/or improvement of diagnostic procedures.
Antibiotic susceptibility testing
For each strain, the antibiotic susceptibility profile for amoxicillin, clindamycin, metronidazole and meropenem was determined using an Etest (Biom erieux, Marcy-l'Etoile, France). Briefly, Brucella blood agar was confluently inoculated with a bacterial suspension of 1 McFarland prepared in saline. After applying an Etest strip, plates were incubated in an anaerobic environment, as mentioned above, at 37 C. After 48 hours of incubation, the MIC value was determined as advised by the manufacturer. The susceptibility testing was part of the diagnostic procedure in our laboratory. Resistance was determined according to the EUCAST guidelines (v6.0).
Prevalence of resistance genes
Isolates belonging to the genus Bacteroides were tested for the presence of cfxA, cepA, cfiA, tetQ, ermF and nim antibiotic-resistance genes and isolates belonging to the genus Prevotella were tested for the presence of cfxA, tetQ, ermF and nim genes using targeted PCR. As a positive control, a Bacteroides strain and a Prevotella strain were used in which antibiotic-resistance genes were known to be present, as assessed by whole genome sequencing. An overview of the primers used in the PCR is shown in the Supplementary material (Table S1 ).
For PCR, DNA was obtained by suspending bacterial colonies in DNAse/RNAse-free water. The PCR mastermix consisted of 100 mL HotStart-Taq mastermix (100 U/mL DNA polymerase, 400 mM of each dNTP; Qiagen, Hilden, Germany), 4 mL of each of the primers (10 mM; Eurogentec, Luik, Belgium) and 84 mL DNAse/RNAse-free water. For each PCR 24 mL PCR mastermix and 1 mL DNA suspension were used, yielding an end concentration of 5 mM per primer.
The PCR reactions were run in a T100™ Thermal cycler (Bio-Rad, Hercules, CA, USA), using the conditions presented in the Supplementary material (Table S1 ). Strains harbouring the cfiA gene were also checked for the presence of an insertion sequence (IS) element upstream of the gene according to the method described by Soki et al. [8] .
Results
Bacterial strains
The most prevalent species within the Bacteroides group were B. fragilis (n ¼ 38), Bacteroides thetaiotaomicron (n ¼ 21), B. ovatus/ xylanisolvens (n ¼ 11) and B. vulgatus/dorei (n ¼ 11). Among the genus Prevotella the most prevalent species were Prevotella melaninogenica (n ¼ 21), Prevotella bivia (n ¼ 17) and Prevotella buccae (n ¼ 13) (Tables 1 and 2) .
Antibiotic susceptibility and prevalence of resistance genes
Only 2 of the 38 tested B. fragilis isolates (5.3%) were meropenem resistant, and the cfiA gene was present in six of the strains (15.8%; Table 1 ). In one isolate an IS-element, upstream of the cfiA gene, was present. Of the six isolates harbouring the cfiA gene, two showed complete resistance to meropenem and four were intermediate resistant (data not shown). The isolate harbouring both the cfiA gene and the IS-element showed complete resistance to meropenem (MIC >32 mg/mL).
Most of the Bacteroides isolates were resistant to amoxicillin. Among the 38 B. fragilis isolates, 34 were was resistant to amoxicillin (89.5%), and the cepA and cfiA genes (with and without ISelement) were present in 31 and 6 isolates (81.6% and 15.8%), respectively. At least one of these two genes was found in 37 of the tested isolates (97.4%). The cfxA gene was found in 14 of the 63 tested non-fragilis species of Bacteroides. However, 48 isolates of B. non-fragilis were resistant to amoxicillin, but did not harbour a cfxA gene.
Resistance to clindamycin differed among the Bacteroides species. In most cases the prevalence of the ermF gene was similar to the number of isolates showing resistance to clindamycin.
A nim gene was present in one of the B. vulgatus/dorei isolates, showing no resistance to metronidazole. All other tested Bacteroides isolates were susceptible to metronidazole and no nim gene was present.
Of all tested Bacteroides isolates, 59 (58.4%) harboured the tetQ gene, among these were all isolates of Bacteroides cellulosilyticus, Bacteroides clarus and Bacteroides stercoris.
None of the 99 tested Prevotella isolates showed resistance to meropenem. The prevalence of resistance against the other tested antibiotics differed depending on the Prevotella species ( Table 2 ). The prevalence of the cfxA gene corresponded with the percentage of resistance against amoxicillin in six of the tested species whereas in the other species a difference in phenotypic resistance and prevalence of the resistance gene was observed.
In general, the prevalence of the ermF gene corresponded with the percentage of clindamycin-resistant isolates; nine isolates harboured the ermF gene and ten were phenotypically resistant.
Metronidazole resistance was observed for one isolate of P. melaninogenica (MIC >256 mg/L) and one isolate of P. bivia (MIC 6 mg/L). The nim gene was detected in the metronidazole-resistant P. bivia isolate. None of the other tested Prevotella isolates harboured this gene.
Of the 99 tested Prevotella isolates, 30 harboured the tetQ gene. Its prevalence was highest in P. bivia and P. bergensis, i.e. 12/17 (70.6%) and 2/3 (66.7%), respectively.
Several Bacteroides isolates harboured more than two antibioticresistance genes ( Table 3 ; see Supplementary material, Table S2 ). Two B. fragilis isolates harboured the cepA, tetQ and ermF genes. In addition, two B. ovatus/xylanisolvens, one B. stercoris and one B. vulgatus/dorei isolate harboured the cfxA, tetQ and ermF genes. Four Prevotella strains harboured three resistance genes (Table 3;  see Supplementary material Table S3 ). One P. bergensis, one Prevotella disiens and one P. melaninogenica isolate harboured the cfxA, tetQ and ermF genes. In addition, one isolate of P. bivia harboured the cfxA, tetQ and nim genes.
Discussion
In this study, we describe the prevalence of antibiotic-resistance genes in human clinical isolates of Bacteroides and Prevotella species, isolated in the Netherlands. Bacteroides fragilis is the most prevalent anaerobic species isolated from human clinical specimens and also the one studied most extensively. Within this species we encountered a prevalence for the cfiA and cepA genes of, Table 1 The number of resistant isolates and the percentage resistance against different antibiotics and the prevalence of corresponding resistance genes in the different species of Bacteroides
Species (n)
Resistant strains, n (%) Prevalence of antibiotic-resistance genes, n (%)
Amoxicillin Meropenem Clindamyin Metronidazole cfxA cepA cfiA IS-element tetQ ermF nim respectively, 15.8% and 81.6%. Together they are responsible for the observed resistance against amoxicillin (89.5%) in the isolates of B. fragilis. Tran et al. [7] , observed a prevalence of 90.4% of the cepA gene in B. fragilis and no cfxA gene, while Eitel et al. [9] reported, for a European study, prevalences of 78.9% and 14.8%, respectively. In this study we report a prevalences of 81.6% and 2.6%, respectively. None of the strains harboured both genes. Gutacker et al. [14] showed that B. fragilis strains belong to two genetic groups, based on the presence of cepA and cfiA: subdivision I, strains harbouring the cepA gene, and subdivision II, strains harbouring the cfiA gene. In this study, 15.8% of the B. fragilis strains belonged to subdivision II and 81.6% to subdivision I. It is noteworthy that in isolates of other Bacteroides species the prevalence of the cfxA gene was lower than the observed resistance for amoxicillin. This indicates that within non-fragilis isolates another antibiotic-resistance gene or mechanism must be present, which is responsible for resistance against b-lactam antibiotics, as reported by Tran et al. [7] . The fact that these strains were shown to produce b-lactamase using a cefinase disc (data not shown), supports this hypothesis. We report prevalences of 15.8% and 9.1% of the ermF gene within the Bacteroides group and Prevotella species, respectively. Boente et al. [15] reported a similar percentage within B. fragilis strains, which were isolated in a clinical setting, whereas Tran et al. [7] reported 28.6%. Within the B. fragilis strains used in this study a prevalence of 12.8% was observed. Remarkably, the prevalence of the ermF gene was much higher within the B. ovatus/xylanisolvens and B. vulgatus/dorei speciesd36.4% and 27.3%, respectively.
The tetQ gene is known to be located on a CTn and can be associated with the ermF gene on the same CTn [16] . Exposing strains harbouring this kind of CTn to low concentrations of tetracycline stimulates the transfer of this CTn. This process also triggers the excision of other mobile elements out of the genome. In this case not only transfer of the CTn harbouring the tetQ and/or ermF gene takes place, but also the transfer of other mobile elements harbouring antibiotic-resistance genes [17] . In this study, the prevalences of the tetQ gene in Bacteroides and Prevotella were 58.4% and 30.3%, respectively. Often not only the tetQ gene is present, but also other antibiotic-resistance genes, cfxA for example. The cfxA gene is known to be located on a transposon, Tn4555 [18] , as is the nimK gene in P. bivia, described in a previous study [19] .
Generally, it is accepted that nim genes play a role in metronidazole resistance, even though the exact resistance mechanism for this antibiotic remains unknown. In this study we encountered a metronidazole-susceptible B. vulgatus/dorei strain harbouring a nim gene, using the described set of primers. Gal and Brazier [20] , reported that silent nim genes can become activated when strains harbouring them are exposed to metronidazole for a prolonged period of time. A new nim gene, nimJ, was found in two multidrugresistant B. fragilis strains [21] . This gene was not detected using the universal nim primers, as we did in this study. Therefore, we cannot exclude that more nim genes are present in our set of isolates.
Sherrard et al. [22] , determined the prevalence of cfxA, tetQ and ermF in Prevotella strains isolated from individuals with cystic fibrosis and those without. A prevalence of 45% for the cfxA gene was observed, which is similar to the prevalence observed in this study, i.e. 50.5%. Furthermore, 4% of the tested strains harboured all three antibiotic-resistance genes. We found a similar number of isolates harbouring three antibiotic-resistance genes, randomly divided among the different species. Arzese et al. [23] reported a prevalence of 20% of the tetQ gene in Prevotella strains, isolated from clinical specimens and healthy individuals, and a prevalence of 8.3% for the ermF genes in the same collection of strains. As in this study, the presence of an ermF gene did not always correspond with the phenotypic susceptibility for clindamycin of isolates. In this study we were confronted with a higher prevalence of the tetQ gene (30.3%) in Prevotella isolates solely isolated from human clinical specimens. As the study by Arzese et al. [23] was performed on strains isolated in 1995e1997, we hypothesize that the prevalence of the tetQ gene (and hereby also the prevalence of CTn) among Prevotella strains is increasing.
Unfortunately, not all species are represented by a sufficient number of strains. Also, the role of efflux pumps in unexplained resistance remains uncertain.
The increase in prevalence and the presence of multiple resistance genes in one isolate warrants further research on this topic, for example whole genome sequencing of these isolates, especially since more and more multidrug-resistant anaerobes are reported.
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